Elsevier

Biochemical Pharmacology

Volume 55, Issue 5, 1 March 1998, Pages 595-603
Biochemical Pharmacology

Research paper
Evidence for co-expression and desensitization of A2a and A2b adenosine receptors in NG108-15 cells

https://doi.org/10.1016/S0006-2952(97)00466-8Get rights and content

Abstract

Using receptor-selective agonists and antagonists, the possible presence of both A2a and A2b adenosine receptor subtypes coupled to activation of adenylyl cyclase was investigated in NG108-15 neuroblastoma × glioma hybrid cells. The relatively non-selective adenosine receptor agonist 5′-(N-ethyl carboxamido)adenosine (NECA; 1 nM–300 μM) produced a biphasic increase in adenylyl cyclase activity in cell homogenates, best fitted to two components with high (ec50 0.7 μM) and low (ec50 16.0 μM) potency, respectively. The selective adenosine A2a receptor agonist CGS-21680 (1 nM–300 μM) also produced a biphasic increase in adenylyl cyclase. The NECA-dependent increase in adenylyl cyclase activity was almost completely inhibited by the non-selective adenosine receptor antagonist xanthine amine congener (XAC; 30 μM), but only partially inhibited by the selective A2a adenosine antagonist 8-(3-chlorostyryl)caffeine (CSC; 1 μM). Experiments were also performed to investigate the time course of NECA-induced desensitization of putative A2a and A2b receptor responses. The A2a-response was quantified using 10 μM CGS-21680, whilst the A2b response was quantified using 100 μM NECA in the presence of 1 μM CSC. The t0.5 for desensitization for each subtype was found to be around 20 min. Neither activation (with dibutyryl cAMP; 1 mM) nor inhibition (with H-89; 10 μM) of cyclic AMP-dependent protein kinase altered the ability of NECA pretreatment to desensitize A2a or A2b receptor-activated adenylyl cyclase. However zinc (200 μM), an inhibitor of G-protein coupled receptor kinase 2 (GRK2), significantly reversed the agonist-induced desensitization of A2a and A2b receptor-activated adenylyl cyclase. These experiments suggest the co-existence of A2a and A2b receptors coupled in a stimulatory fashion to adenylyl cyclase in NG108-15 cells. Furthermore desensitization of A2a and A2b responses occurs at the same rate and may involve a G-protein-coupled receptor kinase.

References (34)

  • G Kong et al.

    A β-adrenergic receptor kinase dominant negative mutant attenuates desensitization of the adrenergic receptor

    J Biol Chem

    (1994)
  • BB Fredholm et al.

    Nomenclature and classification of purinoceptors

    Pharmacol Rev

    (1994)
  • JH Stehle et al.

    Molecular cloning and expression of the cDNA for a novel adenosine receptor subtype

    Mol Endocrinol

    (1992)
  • SA Rivkees et al.

    RFL9 encodes an A2b adenosine receptor

    Mol Endocrinol

    (1992)
  • MF Jarvis et al.

    3HCGS-21680, a selective A2 adenosine receptor agonist, directly labels A2 receptors in rat brain

    J Pharmacol Exp Ther

    (1989)
  • RF Bruns et al.

    Characterization of the A2 adenosine receptor labelled by [3H]-NECA in rat striatal membranes

    Mol Pharmacol

    (1986)
  • NK Puffinbarger et al.

    Production and characterization of multiple antigenic peptide antibodies to the adenosine A2b receptor

    Mol Pharmacol

    (1995)
  • Cited by (0)

    This study was supported by the Medical Research Council.

    View full text